THERMO FISHER SCIENTIFIC INC. (TMO) — SEC Filings

Latest SEC filings for THERMO FISHER SCIENTIFIC INC. (TMO), explained in plain English.

Sentiment Overview: 1 bullish, 31 neutral, 2 mixed

Recent Filings (34)

• Thermo Fisher Files 8-K for 'Other Event' on March 24, 2026 — 8-K · 2026-03-24T08:02:35-04:00 [neutral]
  Thermo Fisher Scientific Inc. filed an 8-K on March 24, 2026, under Item 8.01, indicating an 'Other Event.' While the filing itself doesn't detail the specific
• Thermo Fisher Scientific Issues Over $19 Billion in Notes — 8-K · 2025-12-01T00:00:00.000Z [neutral] Risk: medium
  Thermo Fisher Scientific Inc. entered into a material definitive agreement on November 24, 2025, related to the issuance of various notes. These include $500 mi
• Thermo Fisher's Q3 Revenue Climbs, Acquisitions Drive Goodwill Surge — 10-Q · 2025-10-31T00:00:00.000Z [mixed] Risk: medium
  Thermo Fisher Scientific Inc. reported total revenues of $11.12 billion for the three months ended September 27, 2025, an increase from $10.60 billion in the pr
• Thermo Fisher Scientific Files 8-K on Debt Offerings — 8-K · 2025-10-29T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on October 29, 2025, reporting on various financial instruments including common stock and multiple series of senior
• Thermo Fisher Scientific Files 8-K on Financials — 8-K · 2025-10-22T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on October 22, 2025, reporting on its financial condition and results of operations. The filing includes details on v
• Thermo Fisher Scientific Issues New Debt — 8-K · 2025-10-07T00:00:00.000Z [neutral] Risk: low
  On October 7, 2025, Thermo Fisher Scientific Inc. entered into a material definitive agreement related to the issuance of various notes. These include $500 mill
• Thermo Fisher Scientific Files 8-K on Senior Notes — 8-K · 2025-09-02T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on September 2, 2025, reporting on various senior notes due between 2026 and 2039. The filing indicates these notes,
• Thermo Fisher Navigates Revenue Dip Amidst Stable Service Growth — 10-Q · 2025-08-01T00:00:00.000Z [mixed] Risk: medium
  Thermo Fisher Scientific Inc. reported total revenue of $10.70 billion for the three months ended June 28, 2025, a decrease from $10.92 billion in the prior-yea
• Thermo Fisher Scientific Files 8-K on Financials — 8-K · 2025-07-23T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on July 23, 2025, related to its financial condition and results of operations. The filing details various senior not
• Thermo Fisher Scientific Files 8-K on Security Holder Votes — 8-K · 2025-05-28T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on May 28, 2025, reporting on the submission of matters to a vote of security holders. The filing details various sen
• Thermo Fisher Scientific Appoints New General Counsel — 8-K · 2025-05-22T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. announced on May 21, 2025, the appointment of Christopher R. Smith as Senior Vice President, General Counsel, and Corporate Secret
• Thermo Fisher Scientific Files Q1 2025 10-Q — 10-Q · 2025-05-02T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its 10-Q for the period ending March 29, 2025. The company reported financial results and provided updates on its business o
• Thermo Fisher Scientific Files 8-K on Financials — 8-K · 2025-04-23T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on April 23, 2025, to report on its results of operations and financial condition, and to file financial statements a
• Thermo Fisher Scientific DEF 14A: Executive Comp & Equity Awards — DEF 14A · 2025-04-08T00:00:00.000Z [neutral] Risk: medium
  Thermo Fisher Scientific Inc. filed its DEF 14A on April 8, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending D
• Thermo Fisher Scientific files Proxy Statement — DEFA14A · 2025-04-08T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its Definitive Proxy Statement (DEFA14A) on April 8, 2025, detailing information for its upcoming shareholder meeting. The f
• Thermo Fisher Scientific Files 8-K on Debt Issuances — 8-K · 2025-02-25T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on February 25, 2025, to report on various debt issuances, including senior notes with varying interest rates and mat
• Thermo Fisher Scientific Files 2024 10-K — 10-K · 2025-02-20T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its 2024 10-K report on February 20, 2025, detailing its financial performance for the fiscal year ending December 31, 2024.
• Thermo Fisher Scientific Announces Officer Departure, Director Changes — 8-K · 2025-02-19T00:00:00.000Z [neutral] Risk: medium
  Thermo Fisher Scientific Inc. announced on February 19, 2025, the departure of its Chief Accounting Officer, Bradley J. Mattson. The company also reported on th
• Thermo Fisher Scientific Files 8-K on Financials and Debt — 8-K · 2025-01-30T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on January 30, 2025, reporting on its financial condition and results of operations. The filing includes various exhi
• Thermo Fisher Scientific Q3 2024 10-Q Filed — 10-Q · 2024-11-01T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its 10-Q for the period ending September 28, 2024. The company's fiscal year ends on December 31st. Key financial data and d
• Thermo Fisher Scientific Files 8-K on Financial Condition — 8-K · 2024-10-23T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on October 23, 2024, related to its results of operations and financial condition. The filing details various senior
• Thermo Fisher Scientific Q2 2024 10-Q Filing — 10-Q · 2024-08-02T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its 10-Q for the period ending June 29, 2024. The filing details financial performance and operational updates for the secon
• Thermo Fisher Scientific Files 8-K on Financials — 8-K · 2024-07-24T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on July 24, 2024, to report results of operations and financial condition. The filing details various senior notes wi
• Thermo Fisher to Acquire Olink for $3.1B — 8-K · 2024-07-10T00:00:00.000Z [bullish] Risk: medium
  Thermo Fisher Scientific Inc. announced on July 10, 2024, that it has entered into a definitive agreement to acquire Olink Holding AB for approximately $3.1 bil
• Thermo Fisher Scientific Files 8-K on Security Holder Votes — 8-K · 2024-05-24T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on May 24, 2024, to report on the submission of matters to a vote of security holders. The filing details various sen
• Thermo Fisher Scientific Q1 2024 10-Q Filed — 10-Q · 2024-05-03T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed its 10-Q for the period ending March 30, 2024. The company reported significant financial activities, including various seni
• Thermo Fisher Scientific Files 8-K on Financials — 8-K · 2024-04-24T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed an 8-K on April 24, 2024, to report results of operations and financial condition, along with financial statements and exhib
• Thermo Fisher Scientific: Executive Compensation & Stock Awards Detailed — DEF 14A · 2024-04-09T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed a DEF 14A on April 9, 2024, detailing executive compensation and stock-based awards. The filing outlines the methodologies f
• Thermo Fisher Scientific Files Definitive Proxy Statement — DEFA14A · 2024-04-09T00:00:00.000Z [neutral] Risk: low
  Thermo Fisher Scientific Inc. filed a Definitive Proxy Statement (DEFA14A) on April 9, 2024. This document, filed under the 1934 Act, serves as the company's of
• Thermo Fisher Scientific Amends Filing for Science 37 Holdings Stake — SC 13D/A · 2024-03-14T00:00:00.000Z [neutral] Risk: medium
  Thermo Fisher Scientific Inc. filed an SC 13D/A amendment on March 14, 2024, related to its ownership of Science 37 Holdings, Inc. The filing indicates a change
• Thermo Fisher Scientific Files 2023 10-K — 10-K · 2024-02-22T00:00:00.000Z [neutral] Risk: medium
  Thermo Fisher Scientific Inc. filed its 10-K on February 22, 2024, for the fiscal year ended December 31, 2023. The company, headquartered in Waltham, MA, opera
• Vanguard Amends Thermo Fisher Stake, Signals Continued Confidence — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral] Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its ownership of Thermo Fisher Scientific Inc. common st
• BlackRock Amends Thermo Fisher Scientific Stake, Passive Holding — SC 13G/A · 2024-02-08T00:00:00.000Z [neutral] Risk: low
  BlackRock Inc. filed an amended SC 13G/A on February 8, 2024, updating its beneficial ownership of Thermo Fisher Scientific Inc. common stock as of December 31,
• Thermo Fisher Updates Senior Notes Debt Profile in 8-K Filing — 8-K · 2024-01-31T00:00:00.000Z [neutral]
  Thermo Fisher Scientific Inc. filed an 8-K on January 31, 2024, primarily to update its financial condition regarding various senior notes. The filing lists num